Salvage carbon dioxide transoral laser microsurgery for laryngeal cancer after (chemo)radiotherapy

To provide expert opinion and consensus on salvage carbon dioxide transoral laser microsurgery (CO TOLMS) for recurrent laryngeal squamous cell carcinoma (LSCC) after (chemo)radiotherapy [(C)RT]. Expert members of the European Laryngological Society (ELS) Cancer and Dysplasia Committee were selected...

Descripción completa

Detalles Bibliográficos
Autores: Piazza, Cesare|||0000-0002-2391-9357, Paderno, Alberto|||0000-0002-1621-2142, Sjögren, Elisabeth|||0000-0001-7990-8510, Bradley, Patrick|||0000-0003-2810-5704, Eckel, Hans Edmund, Mäkitie, Antti A.|||0000-0002-0451-2404, Matar, Nayla, Paleri, Vinidh, Peretti, Giorgio, Puxeddu, Roberto, Quer, Miquel|||0000-0003-2563-6729, Remacle, Marc, Vander Poorten, Vincent|||0000-0003-1341-829X, Vilaseca, Isabel|||0000-0003-4399-5522, Simo, Ricard
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:250436
Acceso en línea:https://ddd.uab.cat/record/250436
https://dx.doi.org/urn:doi:10.1007/s00405-021-06957-5
Access Level:acceso abierto
Palabra clave:Carbon dioxide laser
Transoral laser microsurgery
Laryngeal cancer
Radiotherapy
Chemoradiation
Salvage surgery
Descripción
Sumario:To provide expert opinion and consensus on salvage carbon dioxide transoral laser microsurgery (CO TOLMS) for recurrent laryngeal squamous cell carcinoma (LSCC) after (chemo)radiotherapy [(C)RT]. Expert members of the European Laryngological Society (ELS) Cancer and Dysplasia Committee were selected to create a dedicated panel on salvage CO TOLMS for LSCC. A series of statements regarding the critical aspects of decision-making were drafted, circulated, and modified or excluded in accordance with the Delphi process. The expert panel reached full consensus on 19 statements through a total of three sequential evaluation rounds. These statements were focused on different aspects of salvage CO TOLMS, with particular attention on preoperative diagnostic work-up, treatment indications, postoperative management, complications, functional outcomes, and follow-up. Management of recurrent LSCC after (C)RT is challenging and is based on the need to find a balance between oncologic and functional outcomes. Salvage CO TOLMS is a minimally invasive approach that can be applied to selected patients with strict and careful indications. Herein, a series of statements based on an ELS expert consensus aimed at guiding the main aspects of CO TOLMS for LSCC in the salvage setting is presented.